- IBDEI0Z3 ; ; 01-FEB-2022
- ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
- Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
- Q Q
- ;;^UTILITY(U,$J,358.3,15840,1,3,0)
- ;;=3^Progressive Systemic Sclerosis
- ;;^UTILITY(U,$J,358.3,15840,1,4,0)
- ;;=4^M34.0
- ;;^UTILITY(U,$J,358.3,15840,2)
- ;;=^5011778
- ;;^UTILITY(U,$J,358.3,15841,0)
- ;;=M34.1^^61^765^92
- ;;^UTILITY(U,$J,358.3,15841,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,15841,1,3,0)
- ;;=3^CR(E)ST Syndrome
- ;;^UTILITY(U,$J,358.3,15841,1,4,0)
- ;;=4^M34.1
- ;;^UTILITY(U,$J,358.3,15841,2)
- ;;=^5011779
- ;;^UTILITY(U,$J,358.3,15842,0)
- ;;=M34.2^^61^765^313
- ;;^UTILITY(U,$J,358.3,15842,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,15842,1,3,0)
- ;;=3^Systemic Sclerosis Induced by Drug/Chemical
- ;;^UTILITY(U,$J,358.3,15842,1,4,0)
- ;;=4^M34.2
- ;;^UTILITY(U,$J,358.3,15842,2)
- ;;=^5011780
- ;;^UTILITY(U,$J,358.3,15843,0)
- ;;=M34.81^^61^765^315
- ;;^UTILITY(U,$J,358.3,15843,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,15843,1,3,0)
- ;;=3^Systemic Sclerosis w/ Lung Involvement
- ;;^UTILITY(U,$J,358.3,15843,1,4,0)
- ;;=4^M34.81
- ;;^UTILITY(U,$J,358.3,15843,2)
- ;;=^5011781
- ;;^UTILITY(U,$J,358.3,15844,0)
- ;;=M34.82^^61^765^316
- ;;^UTILITY(U,$J,358.3,15844,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,15844,1,3,0)
- ;;=3^Systemic Sclerosis w/ Myopathy
- ;;^UTILITY(U,$J,358.3,15844,1,4,0)
- ;;=4^M34.82
- ;;^UTILITY(U,$J,358.3,15844,2)
- ;;=^5011782
- ;;^UTILITY(U,$J,358.3,15845,0)
- ;;=M34.83^^61^765^317
- ;;^UTILITY(U,$J,358.3,15845,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,15845,1,3,0)
- ;;=3^Systemic Sclerosis w/ Polyneuropathy
- ;;^UTILITY(U,$J,358.3,15845,1,4,0)
- ;;=4^M34.83
- ;;^UTILITY(U,$J,358.3,15845,2)
- ;;=^5011783
- ;;^UTILITY(U,$J,358.3,15846,0)
- ;;=M34.89^^61^765^314
- ;;^UTILITY(U,$J,358.3,15846,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,15846,1,3,0)
- ;;=3^Systemic Sclerosis NEC
- ;;^UTILITY(U,$J,358.3,15846,1,4,0)
- ;;=4^M34.89
- ;;^UTILITY(U,$J,358.3,15846,2)
- ;;=^5011784
- ;;^UTILITY(U,$J,358.3,15847,0)
- ;;=M34.9^^61^765^318
- ;;^UTILITY(U,$J,358.3,15847,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,15847,1,3,0)
- ;;=3^Systemic Sclerosis,Unspec
- ;;^UTILITY(U,$J,358.3,15847,1,4,0)
- ;;=4^M34.9
- ;;^UTILITY(U,$J,358.3,15847,2)
- ;;=^5011785
- ;;^UTILITY(U,$J,358.3,15848,0)
- ;;=R21.^^61^765^297
- ;;^UTILITY(U,$J,358.3,15848,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,15848,1,3,0)
- ;;=3^Rash/Nonspecific Skin Eruption
- ;;^UTILITY(U,$J,358.3,15848,1,4,0)
- ;;=4^R21.
- ;;^UTILITY(U,$J,358.3,15848,2)
- ;;=^5019283
- ;;^UTILITY(U,$J,358.3,15849,0)
- ;;=R23.3^^61^765^309
- ;;^UTILITY(U,$J,358.3,15849,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,15849,1,3,0)
- ;;=3^Spontaneous Ecchymoses
- ;;^UTILITY(U,$J,358.3,15849,1,4,0)
- ;;=4^R23.3
- ;;^UTILITY(U,$J,358.3,15849,2)
- ;;=^5019295
- ;;^UTILITY(U,$J,358.3,15850,0)
- ;;=L03.113^^61^765^114
- ;;^UTILITY(U,$J,358.3,15850,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,15850,1,3,0)
- ;;=3^Cellulitis of Right Upper Limb
- ;;^UTILITY(U,$J,358.3,15850,1,4,0)
- ;;=4^L03.113
- ;;^UTILITY(U,$J,358.3,15850,2)
- ;;=^5009033
- ;;^UTILITY(U,$J,358.3,15851,0)
- ;;=L03.114^^61^765^107
- ;;^UTILITY(U,$J,358.3,15851,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,15851,1,3,0)
- ;;=3^Cellulitis of Left Upper Limb
- ;;^UTILITY(U,$J,358.3,15851,1,4,0)
- ;;=4^L03.114
- ;;^UTILITY(U,$J,358.3,15851,2)
- ;;=^5009034
- ;;^UTILITY(U,$J,358.3,15852,0)
- ;;=L03.115^^61^765^111
- ;;^UTILITY(U,$J,358.3,15852,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,15852,1,3,0)
- ;;=3^Cellulitis of Right Lower Limb
- ;;^UTILITY(U,$J,358.3,15852,1,4,0)
- ;;=4^L03.115
- --- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI0Z3 3773 printed Feb 18, 2025@23:24:56 Page 2
- IBDEI0Z3 ; ; 01-FEB-2022
- +1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
- +2 if 'DIFQR(358.3)
- QUIT
- FOR I=1:2
- SET X=$TEXT(Q+I)
- if X=""
- QUIT
- SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
- SET X=$EXTRACT(X,4,999)
- if $ASCII(Y)=126
- SET I=I+1
- SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
- if $ASCII(Y)=61
- SET Y=$EXTRACT(Y,2,999)
- XECUTE NO
- IF '$TEST
- SET @X=Y
- Q QUIT
- +1 ;;^UTILITY(U,$J,358.3,15840,1,3,0)
- +2 ;;=3^Progressive Systemic Sclerosis
- +3 ;;^UTILITY(U,$J,358.3,15840,1,4,0)
- +4 ;;=4^M34.0
- +5 ;;^UTILITY(U,$J,358.3,15840,2)
- +6 ;;=^5011778
- +7 ;;^UTILITY(U,$J,358.3,15841,0)
- +8 ;;=M34.1^^61^765^92
- +9 ;;^UTILITY(U,$J,358.3,15841,1,0)
- +10 ;;=^358.31IA^4^2
- +11 ;;^UTILITY(U,$J,358.3,15841,1,3,0)
- +12 ;;=3^CR(E)ST Syndrome
- +13 ;;^UTILITY(U,$J,358.3,15841,1,4,0)
- +14 ;;=4^M34.1
- +15 ;;^UTILITY(U,$J,358.3,15841,2)
- +16 ;;=^5011779
- +17 ;;^UTILITY(U,$J,358.3,15842,0)
- +18 ;;=M34.2^^61^765^313
- +19 ;;^UTILITY(U,$J,358.3,15842,1,0)
- +20 ;;=^358.31IA^4^2
- +21 ;;^UTILITY(U,$J,358.3,15842,1,3,0)
- +22 ;;=3^Systemic Sclerosis Induced by Drug/Chemical
- +23 ;;^UTILITY(U,$J,358.3,15842,1,4,0)
- +24 ;;=4^M34.2
- +25 ;;^UTILITY(U,$J,358.3,15842,2)
- +26 ;;=^5011780
- +27 ;;^UTILITY(U,$J,358.3,15843,0)
- +28 ;;=M34.81^^61^765^315
- +29 ;;^UTILITY(U,$J,358.3,15843,1,0)
- +30 ;;=^358.31IA^4^2
- +31 ;;^UTILITY(U,$J,358.3,15843,1,3,0)
- +32 ;;=3^Systemic Sclerosis w/ Lung Involvement
- +33 ;;^UTILITY(U,$J,358.3,15843,1,4,0)
- +34 ;;=4^M34.81
- +35 ;;^UTILITY(U,$J,358.3,15843,2)
- +36 ;;=^5011781
- +37 ;;^UTILITY(U,$J,358.3,15844,0)
- +38 ;;=M34.82^^61^765^316
- +39 ;;^UTILITY(U,$J,358.3,15844,1,0)
- +40 ;;=^358.31IA^4^2
- +41 ;;^UTILITY(U,$J,358.3,15844,1,3,0)
- +42 ;;=3^Systemic Sclerosis w/ Myopathy
- +43 ;;^UTILITY(U,$J,358.3,15844,1,4,0)
- +44 ;;=4^M34.82
- +45 ;;^UTILITY(U,$J,358.3,15844,2)
- +46 ;;=^5011782
- +47 ;;^UTILITY(U,$J,358.3,15845,0)
- +48 ;;=M34.83^^61^765^317
- +49 ;;^UTILITY(U,$J,358.3,15845,1,0)
- +50 ;;=^358.31IA^4^2
- +51 ;;^UTILITY(U,$J,358.3,15845,1,3,0)
- +52 ;;=3^Systemic Sclerosis w/ Polyneuropathy
- +53 ;;^UTILITY(U,$J,358.3,15845,1,4,0)
- +54 ;;=4^M34.83
- +55 ;;^UTILITY(U,$J,358.3,15845,2)
- +56 ;;=^5011783
- +57 ;;^UTILITY(U,$J,358.3,15846,0)
- +58 ;;=M34.89^^61^765^314
- +59 ;;^UTILITY(U,$J,358.3,15846,1,0)
- +60 ;;=^358.31IA^4^2
- +61 ;;^UTILITY(U,$J,358.3,15846,1,3,0)
- +62 ;;=3^Systemic Sclerosis NEC
- +63 ;;^UTILITY(U,$J,358.3,15846,1,4,0)
- +64 ;;=4^M34.89
- +65 ;;^UTILITY(U,$J,358.3,15846,2)
- +66 ;;=^5011784
- +67 ;;^UTILITY(U,$J,358.3,15847,0)
- +68 ;;=M34.9^^61^765^318
- +69 ;;^UTILITY(U,$J,358.3,15847,1,0)
- +70 ;;=^358.31IA^4^2
- +71 ;;^UTILITY(U,$J,358.3,15847,1,3,0)
- +72 ;;=3^Systemic Sclerosis,Unspec
- +73 ;;^UTILITY(U,$J,358.3,15847,1,4,0)
- +74 ;;=4^M34.9
- +75 ;;^UTILITY(U,$J,358.3,15847,2)
- +76 ;;=^5011785
- +77 ;;^UTILITY(U,$J,358.3,15848,0)
- +78 ;;=R21.^^61^765^297
- +79 ;;^UTILITY(U,$J,358.3,15848,1,0)
- +80 ;;=^358.31IA^4^2
- +81 ;;^UTILITY(U,$J,358.3,15848,1,3,0)
- +82 ;;=3^Rash/Nonspecific Skin Eruption
- +83 ;;^UTILITY(U,$J,358.3,15848,1,4,0)
- +84 ;;=4^R21.
- +85 ;;^UTILITY(U,$J,358.3,15848,2)
- +86 ;;=^5019283
- +87 ;;^UTILITY(U,$J,358.3,15849,0)
- +88 ;;=R23.3^^61^765^309
- +89 ;;^UTILITY(U,$J,358.3,15849,1,0)
- +90 ;;=^358.31IA^4^2
- +91 ;;^UTILITY(U,$J,358.3,15849,1,3,0)
- +92 ;;=3^Spontaneous Ecchymoses
- +93 ;;^UTILITY(U,$J,358.3,15849,1,4,0)
- +94 ;;=4^R23.3
- +95 ;;^UTILITY(U,$J,358.3,15849,2)
- +96 ;;=^5019295
- +97 ;;^UTILITY(U,$J,358.3,15850,0)
- +98 ;;=L03.113^^61^765^114
- +99 ;;^UTILITY(U,$J,358.3,15850,1,0)
- +100 ;;=^358.31IA^4^2
- +101 ;;^UTILITY(U,$J,358.3,15850,1,3,0)
- +102 ;;=3^Cellulitis of Right Upper Limb
- +103 ;;^UTILITY(U,$J,358.3,15850,1,4,0)
- +104 ;;=4^L03.113
- +105 ;;^UTILITY(U,$J,358.3,15850,2)
- +106 ;;=^5009033
- +107 ;;^UTILITY(U,$J,358.3,15851,0)
- +108 ;;=L03.114^^61^765^107
- +109 ;;^UTILITY(U,$J,358.3,15851,1,0)
- +110 ;;=^358.31IA^4^2
- +111 ;;^UTILITY(U,$J,358.3,15851,1,3,0)
- +112 ;;=3^Cellulitis of Left Upper Limb
- +113 ;;^UTILITY(U,$J,358.3,15851,1,4,0)
- +114 ;;=4^L03.114
- +115 ;;^UTILITY(U,$J,358.3,15851,2)
- +116 ;;=^5009034
- +117 ;;^UTILITY(U,$J,358.3,15852,0)
- +118 ;;=L03.115^^61^765^111
- +119 ;;^UTILITY(U,$J,358.3,15852,1,0)
- +120 ;;=^358.31IA^4^2
- +121 ;;^UTILITY(U,$J,358.3,15852,1,3,0)
- +122 ;;=3^Cellulitis of Right Lower Limb
- +123 ;;^UTILITY(U,$J,358.3,15852,1,4,0)
- +124 ;;=4^L03.115
